Literature DB >> 31424086

Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.

Maarten van der Kroef1,2, Lucas L van den Hoogen1,2, Jorre S Mertens1,2,3, Sofie L M Blokland1,2, Scott Haskett4, Abhinandan Devaprasad1,2, Tiago Carvalheiro1,2, Eleni Chouri1,2, Nadia Vazirpanah1,2, Marta Cossu1,2, Catherina G K Wichers1,2, Sandra C Silva-Cardoso1,2, Alsya J Affandi1,2, Cornelis P J Bekker1,2, Ana P Lopes1,2, Maarten R Hillen1,2, Femke Bonte-Mineur5, Marc R Kok5, Lorenzo Beretta6, Marzia Rossato1,2,7, Michaël Mingueneau4, Joel A G van Roon1,2, Timothy R D J Radstake1,2.   

Abstract

Systemic sclerosis (SSc), systemic lupus erythematosus (SLE) and primary Sjögrens syndrome (pSS) are clinically distinct systemic autoimmune diseases (SADs) that share molecular pathways. We quantified the frequency of circulating immune-cells in 169 patients with these SADs and 44 healty controls (HC) using mass-cytometry and assessed the diagnostic value of these results. Alterations in the frequency of immune-cell subsets were present in all SADs compared to HC. Most alterations, including a decrease of CD56hi NK-cells in SSc and IgM+ Bcells in pSS, were disease specific; only a reduced frequency of plasmacytoid dendritic cells was common between all SADs Strikingly, hierarchical clustering of SSc patients identified 4 clusters associated with different clinical phenotypes, and 9 of the 12 cell subset-alterations in SSc were also present during the preclinical-phase of the disease. Additionally, we found a strong association between the use of prednisone and alterations in B-cell subsets. Although differences in immune-cell frequencies between these SADs are apparent, the discriminative value thereof is too low for diagnostic purposes. Within each disease, mass cytometry analyses revealed distinct patterns between endophenotypes. Given the lack of tools enabling early diagnosis of SSc, our results justify further research into the value of cellular phenotyping as a diagnostic aid.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CyTOF; Sjögren's syndrome; immunophenotyping; systemic lupus erythematosus; systemic sclerosis

Mesh:

Year:  2019        PMID: 31424086     DOI: 10.1002/eji.201948129

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

Review 1.  The promise of precision medicine in rheumatology.

Authors:  Joel M Guthridge; Catriona A Wagner; Judith A James
Journal:  Nat Med       Date:  2022-07-04       Impact factor: 87.241

Review 2.  Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells.

Authors:  Konstantinos Melissaropoulos; George Iliopoulos; Lazaros I Sakkas; Dimitrios Daoussis
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

3.  Characterization of Long Non-Coding RNAs in Systemic Sclerosis Monocytes: A Potential Role for PSMB8-AS1 in Altered Cytokine Secretion.

Authors:  Nila H Servaas; Barbara Mariotti; Maarten van der Kroef; Catharina G K Wichers; Aridaman Pandit; Flavia Bazzoni; Timothy R D J Radstake; Marzia Rossato
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 4.  Emerging Roles of Matricellular Proteins in Systemic Sclerosis.

Authors:  Daniel Feng; Casimiro Gerarduzzi
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

Review 5.  NK Cells in Autoimmune Diseases: Protective or Pathogenic?

Authors:  Meifang Liu; Shujuan Liang; Cai Zhang
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

Review 6.  Novel Technologies in Studying Brain Immune Response.

Authors:  Li Li; Cameron Lenahan; Zhihui Liao; Jingdong Ke; Xiuliang Li; Fushan Xue; John H Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-03-18       Impact factor: 6.543

Review 7.  Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?

Authors:  Elena Gianchecchi; Domenico V Delfino; Alessandra Fierabracci
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

8.  Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation.

Authors:  Michael Gernert; Hans-Peter Tony; Eva Christina Schwaneck; Matthias Fröhlich; Marc Schmalzing
Journal:  Arthritis Res Ther       Date:  2020-08-08       Impact factor: 5.156

9.  Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets.

Authors:  Louise Magnusson; Hugo Barcenilla; Mikael Pihl; Sophie Bensing; Daniel Espes; Per-Ola Carlsson; Rosaura Casas
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

Review 10.  Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).

Authors:  Padmini Khedoe; Emiel Marges; Pieter Hiemstra; Maarten Ninaber; Miranda Geelhoed
Journal:  Front Immunol       Date:  2020-09-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.